全文获取类型
收费全文 | 12047篇 |
免费 | 772篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 451篇 |
妇产科学 | 322篇 |
基础医学 | 1523篇 |
口腔科学 | 75篇 |
临床医学 | 2183篇 |
内科学 | 1989篇 |
皮肤病学 | 111篇 |
神经病学 | 1026篇 |
特种医学 | 276篇 |
外科学 | 1085篇 |
综合类 | 140篇 |
一般理论 | 8篇 |
预防医学 | 1761篇 |
眼科学 | 115篇 |
药学 | 702篇 |
中国医学 | 7篇 |
肿瘤学 | 1005篇 |
出版年
2023年 | 57篇 |
2022年 | 91篇 |
2021年 | 187篇 |
2020年 | 120篇 |
2019年 | 193篇 |
2018年 | 244篇 |
2017年 | 224篇 |
2016年 | 192篇 |
2015年 | 224篇 |
2014年 | 373篇 |
2013年 | 584篇 |
2012年 | 826篇 |
2011年 | 906篇 |
2010年 | 510篇 |
2009年 | 457篇 |
2008年 | 792篇 |
2007年 | 887篇 |
2006年 | 855篇 |
2005年 | 922篇 |
2004年 | 928篇 |
2003年 | 848篇 |
2002年 | 779篇 |
2001年 | 100篇 |
2000年 | 83篇 |
1999年 | 106篇 |
1998年 | 147篇 |
1997年 | 126篇 |
1996年 | 102篇 |
1995年 | 80篇 |
1994年 | 82篇 |
1993年 | 93篇 |
1992年 | 64篇 |
1991年 | 62篇 |
1990年 | 53篇 |
1989年 | 29篇 |
1988年 | 40篇 |
1987年 | 27篇 |
1986年 | 34篇 |
1985年 | 34篇 |
1984年 | 50篇 |
1983年 | 40篇 |
1982年 | 46篇 |
1981年 | 42篇 |
1980年 | 36篇 |
1979年 | 22篇 |
1978年 | 12篇 |
1977年 | 17篇 |
1976年 | 14篇 |
1974年 | 15篇 |
1972年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
121.
Dunn Jennifer A. Hackney Jonathan J. Martin Rachelle A. Tietjens Donna Young Timothy Bourke John A. Snell Deborah L. Nunnerley Joanne L. Hall Andrew Derrett Sarah 《Journal of occupational rehabilitation》2021,31(4):730-743
Journal of Occupational Rehabilitation - Purpose Little is currently known about how early intervention vocational rehabilitation (EIVR) works for people with newly acquired neurological conditions... 相似文献
122.
123.
124.
Douglas P. Slakey James S. George Edwin Anderson Donna Willeumier Kelly Guglielmi 《American journal of surgery》2021,221(3):598-601
BackgroundEfforts to improve surgical safety are limited by several factors and no consensus exists regarding the most effective way to improve surgical quality. The use of ISO 9001 quality standards within healthcare is recognized but has not been widely applied for improving surgical outcomes.MethodsA surgical quality committee was created using ISO 9001:2015 standards. Quality objectives were assessed to understand how any suggested changes will be impacted due to risks and opportunities inherent in the system.ResultsThe initial quality focus was on surgical site infections in 5 services. Change in surgical infection ratio from 2018 to 2019 showed significant improvement: coronary bypass 1.288 vs. 0.901; Colon 1.359 vs. 0.589; Hysterectomy 2.119 vs. 1.022; Knee 1.391 vs. 0.306; Hip 0 vs. 0.302.ConclusionsThis is one of the first studies using ISO 9001 to improve surgical quality. The results indicate both acceptance and success of applying continual improvement strategies. 相似文献
125.
Michael J. Zobel Donna Nowicki Gabriel Gomez Jessica Lee Lori Howell Joseph Miller Chadi Zeinati Dean M. Anselmo 《Journal of pediatric surgery》2021,56(5):1062-1067
Background/PurposeCervicofacial lymphatic malformations (CFLM) are rare, potentially life-threatening vascular anomalies, yet reports on multidisciplinary treatment strategies are lacking. We evaluated outcomes for CFLMs following sclerotherapy, surgical resection, and/or medical management.MethodsWe identified children with a CFLM at a vascular anomalies center from 2004 to 2019. Exclusion criteria: retro-orbital malformations, untreated malformations, patients without follow-up. Primary clinical outcome was contour improvement, with significance defined as LM volume reduction of > 50% by cross-sectional imaging.ResultsSixty-three children met inclusion criteria: 35 with macrocystic CFLMs, six with microcystic CFLMs, and 22 with mixed-type malformations. Mean post-intervention follow-up was 27.5 months. Fifty-eight patients underwent sclerotherapy (median: two treatments). Doxycycline and/or bleomycin were used in 95% of patients. After sclerotherapy, 97% of macrocystic CFLMs improved significantly compared to 82% of mixed and 67% of microcystic lesions. Sixteen children underwent surgical resection with 75% significantly improving; two additional patients were successfully treated with sclerotherapy after debulking surgery. Six children received sirolimus for microcystic disease, of which 33% significantly improved.ConclusionSclerotherapy is very effective for macrocystic components of CFLMs, albeit less so for microcystic disease. Microcystic CFLMs frequently require surgical resection. Sirolimus is a helpful therapeutic adjunct, particularly for microcystic lesions, but more study is needed.Level of EvidenceLevel II, prognosis study 相似文献
126.
Re-evaluating Blood Markers as Predictors of Outcome in Multivisceral and Intestinal Transplantation
Donna Cheung Jennifer Garcia Thiago Beduschi Amber Langshaw Kristopher Arheart Chris Wunsch Rodrigo Vianna Ivan A. Gonzalez 《Transplantation proceedings》2021,53(2):696-704
BackgroundMultivisceral transplant (MVTx) and isolated intestinal transplant (ITx) are complex surgical procedures. The subsequent proinflammatory state in the immediate postoperative period makes interpretation of blood markers difficult.MethodWe aimed to establish the course of various blood markers after MVTx/ITx, and to evaluate their use as diagnostic markers of complications. This was a single center prospective cohort. We analyzed blood markers collected preoperatively, on alternate days for the first postoperative week, and then weekly for 4 weeks. This study was in compliance with The Declaration of Helsinki.ResultsOver a 16-month period (July 2017-October 2018), 20 subjects aged 2 to 67 years with a median age of 24.5 years received MVTx/ITx. Twelve recipients (60%) had an infection. Neutrophil lymphocyte count ratio (NLCR) was higher than established upper limits of normal, regardless of infection status. NLCR and white blood cell count were useful to identify infected MVTx/ITx recipients, with P values <.05 for 2 and 1 of 7 time points post transplant, respectively. Higher preoperative eosinophil% predicted future acute cellular rejection (P value .023).ConclusionsThis is the first study to extensively track the course of blood markers post MVTx/ITx and identified NLCR and white blood cell count as potential diagnostic blood markers of infection. 相似文献
127.
128.
Joel P. Bish Akshay Pendyal Lijun Ding Heather Ferrante Vy Nguyen Donna McDonald-McGinn Elaine Zackai Tony J. Simon 《Neuroscience letters》2006
Children with chromosome 22q11.2 deletion syndrome commonly are found to have morphological brain changes, cognitive impairments, and elevated rates of psychopathology. One of the most commonly and consistently reported brain changes is reduced cerebellar volume. Here, we demonstrate that, in addition to the global cerebellum reductions previously reported, volumetric reductions of the anterior lobule and the vermal region of the neo-cerebellum in the mid-sagittal plane best differentiate children with the deletion from typically developing children. These results suggest that the morphological changes of specific portions of the cerebellum may be an important underlying substrate of cognitive impairments and increased incidence of psychopathology in this group. 相似文献
129.
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant 总被引:5,自引:0,他引:5
McNeel DG Knutson KL Schiffman K Davis DR Caron D Disis ML 《Journal of clinical immunology》2003,23(1):62-72
A pilot vaccine study was conducted to test the safety and immunological efficacy of four monthly immunizations of an MHC class I peptide vaccine, the E75 HLA-A2 epitope from HER-2/neu, using flt3 ligand as a systemic vaccine adjuvant. Twenty HLA-A2-expressing subjects with advanced stage prostate cancer were randomly assigned to one of four immunization or treatment schedules: (a) Flt3 ligand (20 g/kg per day) administered subcutaneously daily for 14 days on a 28-day cycle, monthly for four months; (b) flt3 ligand course as above with the E75 peptide vaccine administered on day 7 of each flt3 ligand cycle; (c) flt3 ligand course as above with the E75 peptide vaccine administered on day 14 of each flt3 ligand cycle; or (d) E75 peptide admixed with granulocyte–macrophage colony-stimulating factor and administered intradermally once every 28 days, as has previously been reported. The primary endpoints of the study were the determination of safety and immunological efficacy in generating E75-specific T cells as determined by peptide-specific interferon-gamma ELIspot. Adverse events included one grade 3 skin reaction and the development of grade 2 autoimmune hypothyroidism in two subjects with preexisting subclinical autoimmune hypothyroidism. Dendritic cells were markedly increased in the peripheral blood of subjects receiving flt3 ligand with each repetitive cycle, but augmentation of antigen-presenting cells within the dermis was not observed. Apart from a single subject, no significant peptide-specific T-cell responses were detected by ELIspot, whereas delayed-type hypersensitivity responses were detectable in control subjects and in subjects receiving peptide vaccine early in the course of flt3 ligand administration. The absence of robust peripheral immune responses in the current study may be attributable to the small numbers of subjects or differences in the subject population. In addition, the inability of flt3 ligand to augment the number of peripheral skin antigen-presenting cells may have contributed to the absence of robust peptide-specific immunity detectable in the peripheral blood of immunized subjects treated with flt3 ligand. 相似文献
130.
Allan M. Lefer Nobuo Aoki Donna Mulloy 《Naunyn-Schmiedeberg's archives of pharmacology》1990,341(3):246-250
Summary Defibrotide is known to enhance prostacyclin (PGI2) release from the vascular endothelium. We investigated the vasoactive effects of defibrotide in isolated rat hearts perfused at constant flow subjected to ischaemia and reperfusion. Defibrotide at 10–7 or 100 g/ml did not exert any direct vasoactive effect on normal rats hearts. However, ischaemia and reperfusion resulted in an impaired vasodilation to acetylcholine, an endothelium-dependent vasodilator. In contrast, the vasodilator response to the endothelium-independent dilator, nitroglycerin, was unaffected. Defibrotide, at 10–7 or 100 g/ml, markedly restored the vasodilation to acetylcholine 10–7 nmol/l to 1 mol/l (P < 0.01) without influencing the vasodilator response to nitroglycerin (2 to 200 g/1). Haemoglobin (150 nmol/l) inhibited the dilation to acetylcholine in response to defibrotide. However, no evidence of (PGI2) release was observed with acetylcholine-induced vasodilation in the presence or absence of defibrotide. Additionally, 10–100 g/ml of defibrotide did not significantly decrease superoxide radicals generated by a xanthine-xanthine oxidase synthetic system under conditions in which superoxide dismutase was effective. Thus, defibrotide appears to exert an endothelium-protective effect preserving endothelium-derived relaxing factor (EDRF) without directly scavenging free signals.Supported in part by Research Grant No. HL-25575 from the National Heart, Lung and Blood Institute of the NIH
Send offprint requests to A. M. Lefer at the above address 相似文献